Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
出版年份 2014 全文链接
标题
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
作者
关键词
TGF-β inhibitor, Galunisertib, First-in-Human Dose, Glioma, Pharmacokinetics, Pharmacodynamics
出版物
INVESTIGATIONAL NEW DRUGS
Volume 33, Issue 2, Pages 357-370
出版商
Springer Nature
发表日期
2014-12-22
DOI
10.1007/s10637-014-0192-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
- (2015) Mengxian Zhang et al. NEOPLASIA
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF- and BMP-Associated Proinflammatory and Proangiogenic Signals
- (2012) P. Flechsig et al. CLINICAL CANCER RESEARCH
- IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
- (2012) Masato Sasaki et al. NATURE
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
- (2012) C. A. Crane et al. NEURO-ONCOLOGY
- Genomic Profiles of Glioma
- (2011) Cameron Brennan Current Neurology and Neuroscience Reports
- Blockade of Cytotoxic T-lymphocyte Antigen-4 by Ipilimumab is Associated with a Profound Long-Lasting Depletion of Foxp3+ Regulatory T Cells: A Mechanistic Explanation for Ipilimumab-Induced Severe Enterocolitis?
- (2011) S. Nancey et al. INFLAMMATORY BOWEL DISEASES
- Pro- and Anti-Inflammatory Cytokines during Immune Stimulation: Modulation of Iron Status and Red Blood Cell Profile
- (2011) A. M. Koorts et al. MEDIATORS OF INFLAMMATION
- VEGFR2 Expression and TGF-β Signaling in Initial and Recurrent High-Grade Human Glioma
- (2011) Elizabeth A. Kuczynski et al. ONCOLOGY
- TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells
- (2011) Dat Q. Tran Journal of Molecular Cell Biology
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
- (2010) P. Sreekanthreddy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFβR therapy
- (2010) Sabine Classen et al. Pharmacogenetics and Genomics
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- TGF-β signalling-related markers in cancer patients with bone metastasis
- (2008) Jose Baselga et al. BIOMARKERS
- Lactate promotes glioma migration by TGF-β2–dependent regulation of matrix metalloproteinase-2
- (2008) Fusun Baumann et al. NEURO-ONCOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search